Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition
Omar SiddiquiMay 01, 2024
0
The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.